抗体

单克隆抗体是由单个B 淋巴细胞克隆所分泌的抗体，由于B 淋巴细胞只能产生一种专有的、针对一种抗原决定簇的抗体，所以具有理化性质高度专一、生物活性单一、与抗原结合特异性强等特点。因此，它也被形象地被称为“生物导弹”，现有的抗体药物大多属于此类抗体。近年来，单克隆抗体药物迅速发展，并逐渐成为生物医药领域发展的主要方向。

TargetMol可为您提供30多种抗体抑制剂，满足您的实验需求。TargetMol始终致力于服务“科研人员”，将热门的研究报道和产品推送给各位科研人员。

Cat. No.	Product Name	CAS No.	Purity
T36653	Anti-SARS-80R mAb Anti-SARS-80R mAb		98%
T36653	Anti-SARS-80R mAb (SARS-80R) is a human IgG1 monoclonal antibody that is derived from CHO cells. Its main function is to selectively bind to the Spike (S1) prote...
T36654	Anti-SARS-CoV-2 Spike mAb (CR3022) Anti-SARS-CoV-2 Spike mAb (CR3022)		98%
T36654	Anti-SARS-CoV-2 Spike mAb (CR3022) is a human monoclonal IgG1 antibody derived from CHO cells. It specifically targets the S1 domain of the Spike protein in both...
T35394	Sintilimab (anti-PD-1) Sintilimab (anti-PD-1)		98%
T35394	Sintilimab (anti-PD-1, IBI 308) 是一种全人源 IgG4 单克隆抗体，可与 T 细胞表面的 PD-1结合，阻断 PD-1/PD-配体 1 (PD-L1) 通路，并重新激活 T 细胞以杀死癌细胞。
T9914	Vedolizumab 维多珠单抗	943609-66-3	98%
T9914	Vedolizumab 是一种人源化单克隆抗体，靶向α4β7整联蛋白，用于溃疡性结肠炎和克罗恩病的相关研究。
T35397	Sacituzumab (anti-Trop-2) Sacituzumab (anti-Trop-2)	1796566-95-4	98%
T35397	Sacituzumab 是一种人源化 IgG1 单克隆抗体，与抗滋养层细胞表面抗原 2 (anti-Trop-2) 结合。Sacituzumab 具有用于转移性三阴性乳腺癌研究的潜力。
T11126	Durvalumab 德瓦鲁单抗	1428935-60-7	98%
T11126	Durvalumab is an anti-PD-L1 monoclonal antibody, humanized.Durvalumab completely blocked the binding of PD-L1 to PD-1 and CD80, and the IC50s were 0.1 and 0.04 n...
T9923	Nimotuzumab 尼妥珠单抗	828933-51-3	98%
T9923	Nimotuzumab 是一种针对表皮生长因子受体 EGFR 的人源化治疗性单克隆抗体。
T36651	Anti-MERS-2E6 mAb Anti-MERS-2E6 mAb		98%
T36651	Anti-MERS-2E6 mAb (MERS-2E6), a human IgG1 neutralizing antibody, is expressed in CHO cells. It effectively competes with the virus Spike protein for binding to ...
T9904	Bevacizumab 贝伐珠单抗	216974-75-3	98%
T9904	Bevacizumab 是人源化的单克隆抗体，能够高亲和力的、特异性的与所有 VEGF-A 结合。
T38951	Isatuximab Isatuximab	1461640-62-9	98%
T38951	Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38 , a protein highly expressed on hematological malignant cells, inclu...
T36655	Anti-Spike-RBD mAb Anti-Spike-RBD mAb		98%
T36655	Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of spike protein and ACE2 is a potential therapeutic approach f...
T9922	Matuzumab 马妥珠单抗	339186-68-4	98%
T9922	Matuzumab 是一种用于癌症治疗的人源化单克隆抗体。它对 EGFR 具有高亲和力，通常与恶性肿瘤中血管的生长有关，从而促进肿瘤的生长和存活。
T35389	Sarilumab (anti-IL-6Rα) Sarilumab (anti-IL-6Rα)		98%
T35389	Sarilumab (anti-IL-6Rα)是人源anti-IL-6Rα单克隆抗体，与膜结合的和可溶性的IL-6Rα以高亲和力结合。MW: 144.13 KD。
T36656	Anti-Spike-RBD Single Domain mAb Anti-Spike-RBD Single Domain mAb		98%
T36656	The Anti-Spike-RBD Single Domain mAb is a monoclonal antibody derived from CHO cells in Alpaca. It is composed of VHH-huFc and exhibits a strong affinity for the...
T12706	Reslizumab 化合物 T12706	241473-69-8	98%
T12706	Reslizumab is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma.
T39057	Rozanolixizumab Rozanolixizumab	1584645-37-3	98%
T39057	Rozanolixizumab (UCB7665) is a humanized monoclonal antibody (IgG4P) that exhibits high affinity for the human neonatal Fc receptor (FcRn). Its application lies ...
T9931	Meplazumab 化合物meplazumab	2413715-21-4	98%
T9931	meplazumab 是一种人源化抗 CD147 抗体，作为 COVID-19 肺炎患者的附加疗法。
T36652	Anti-MERS-3A1 mAb Anti-MERS-3A1 mAb		98%
T36652	Anti-MERS-3A1 mAb (MERS-3A1) is a high-affinity human monoclonal IgG1 antibody derived from CHO cells. It effectively inhibits the interaction between the MERS-C...
T35396	Spartalizumab (anti-PD-1) Spartalizumab (anti-PD-1)		98%
T35396	Spartalizumab (anti-PD-1)是一种针对PD-1的人源IgG4抗体，抑制PD-L1和PD-L2与PD-1的结合。PDR001可与PD-1以高亲和力结合，抑制其生物活性；MW: 145.8 KD。
T9917	Denosumab 地诺单抗	615258-40-7	98%
T9917	Denosumab 是能够结合并抑制RANKL 受体激活因子的人单克隆抗体。它具有抗癌活性，可降髋部、低椎骨以及非椎骨骨折的风险。